Showing results (41-50 of 283) with videos related to
Sort By:
Pageof 29
The American Journal of Pathology|September 24, 2014
Hepatitis C virus core protein suppresses mitophagy by interacting with parkin in the context of mitochondrial depolarizationYuichi Hara, Izumi Yanatori, Masanori Ikeda, et al.The Journal of Clinical Investigation|October 7, 2009
Adoptive immunotherapy with liver allograft-derived lymphocytes induces anti-HCV activity after liver transplantation in humans and humanized miceMasahiro Ohira, Kohei Ishiyama, Yuka Tanaka, et al.Plos One|September 22, 2022
Patient-derived monoclonal antibody neutralizes HCV infection in vitro and vivo without generating escape mutantsHiroshi Yokokawa, Midori Shinohara, Yuji Teraoka, et al.AJR. American Journal of Roentgenology|April 18, 2002
Balloon-occluded retrograde transvenous obliteration of gastric fundal varices with hemorrhageMikiya Kitamoto, Michio Imamura, Koji Kamada, et al.Journal of Medical Virology|July 9, 2011
Inverse association of IL28B genotype and liver mRNA expression of genes promoting or suppressing antiviral stateHiromi Abe, C Nelson Hayes, Hidenori Ochi, et al.The Journal of Infectious Diseases|June 16, 2011
Effects of hepatitis B virus infection on the interferon response in immunodeficient human hepatocyte chimeric miceMasataka Tsuge, Shoichi Takahashi, Nobuhiko Hiraga, et al.Journal of Gastroenterology and Hepatology|November 27, 2008
Dose comparison study of pegylated interferon-alpha-2b plus ribavirin in naïve Japanese patients with hepatitis C virus genotype 2: a randomized clinical trialTomokazu Kawaoka, Yoshiiku Kawakami, Keiji Tsuji, et al.Clinical Journal of Gastroenterology|February 23, 2017
Three patients treated with sofosbuvir plus ledipasvir for recurrent hepatitis C after liver transplantationTomokazu Kawaoka, Michio Imamura, Kei Morio, et al.Gut|November 12, 2010
HCV substitutions and IL28B polymorphisms on outcome of peg-interferon plus ribavirin combination therapyC Nelson Hayes, Mariko Kobayashi, Norio Akuta, et al.Journal of Medical Virology|May 9, 2015
Long term persistence of NS5A inhibitor-resistant hepatitis C virus in patients who failed daclatasvir and asunaprevir therapySatoshi Yoshimi, Michio Imamura, Eisuke Murakami, et al.Pageof 29